DOR BioPharma, Inc. (DORB) Announces Expansion of Named Patient Access Collaboration With BurnsAdler Pharmaceuticals, Inc. Into Canada
10/30/2008 8:35:56 AM
More...
|
DOR BioPharma, Inc. (DORB) Announces Named Patient Access Program for Latin America in Collaboration With BurnsAdler Pharmaceuticals, Inc.
9/10/2008 9:56:10 AM
More...
|
BurnsAdler Pharmaceuticals, Inc. Release: Collatamp(TM) EG Receives Marketing Authorization in Brazil
4/8/2008 10:32:28 AM
More...
|
BurnsAdler Pharmaceuticals, Inc. Partners With X-GEN Pharmaceuticals to Return Colistimethate for Injection to the Mexican Market
3/6/2007 10:39:09 AM
More...
|
Innocoll, Inc. Announces Expansion Of The Distribution Partnership With BurnsAdler Pharmaceuticals, Inc.
1/17/2007 9:34:35 AM
More...
|
BurnsAdler Pharmaceuticals, Inc. And Serral, S.A. de C.V. Enter Into A Promotional Agreement For Gentamicin Surgical Implant
1/12/2007 10:29:17 AM
More...
|
BurnsAdler Pharmaceuticals, Inc. Licenses Gentamicin Surgical Implant From Innocoll, Inc.
8/1/2006 11:48:17 AM
More...
|
Innocoll, Inc. Announces A Distribution Partnership For Central And South America And The Caribbean For Its CollaRx GENTAMICIN SURGICAL IMPLANT
8/1/2006 11:13:10 AM
More...
|
BurnsAdler Pharmaceuticals, Inc. Licenses NeoVisc® From Stellar Pharmaceuticals Inc. (SLX.V)
2/1/2006 11:08:55 PM
More...
|
BurnsAdler Pharmaceuticals, Inc. Licenses Anti-Epileptic Portfolio From Desitin Arzneimittel GmbH
2/1/2006 11:07:04 PM
More...
|
|